Page last updated: 2024-08-26

bismuth and Prostatic Neoplasms, Castration-Resistant

bismuth has been researched along with Prostatic Neoplasms, Castration-Resistant in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dizdarevic, S; McCready, R; Vinjamuri, S1
Knoesen, O; Marx, S; Meckel, M; Modiselle, M; Sathekge, M; Vorster, M1

Reviews

1 review(s) available for bismuth and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Radium-223 dichloride in prostate cancer: proof of principle for the use of targeted alpha treatment in clinical practice.
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:1

    Topics: Actinium; Astatine; Bismuth; Bone Neoplasms; Humans; Lead Radioisotopes; Male; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Thorium

2020

Other Studies

1 other study(ies) available for bismuth and Prostatic Neoplasms, Castration-Resistant

ArticleYear
    European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:6

    Topics: Alpha Particles; Bismuth; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Male; Molecular Targeted Therapy; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes

2017